Intercept Pharmaceuticals, Inc.
Compositions of obeticholic acid and methods of use
Last updated:
Abstract:
The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions.
Status:
Grant
Type:
Utility
Filling date:
9 Jul 2018
Issue date:
12 May 2020